Clinical Trial Update: Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fed Conditions [Phase 1]

View source ↗

Summary

Torrent Pharmaceuticals completed a Phase 1 bioequivalence study of Alfuzosin extended-release tablets in healthy volunteers under fed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alfuzosin ER (alfuzosin)

Snippet

Sponsor: Torrent Pharmaceuticals Limited | Conditions: Healthy | Phase 1 | Status: COMPLETED